Dr Sudipto Bari

Dr Sudipto Bari

Senior Research Fellow &
Principal Medical Laboratory Scientist
Division of Medical Sciences
National Cancer Centre Singapore

Senior Project Administrator (PTP Scheme)
Hospital Services Division
Ministry of Health (MOH)

SingHealth Duke-NUS
Oncology Academic Clinical Programme

Dr Sudipto Bari is Senior Research Fellow in Division of Medical Sciences in National Cancer Centre Singapore (NCCS). He concurrently serves as a Senior Project Administrator under the PTP Scheme of MOH through which he is an active member of the Implementation Office that is setting up the Advanced Cell Therapy and Research Institute, Singapore (ACTRIS).

Dr Bari graduated from the National University of Singapore (NUS) with a Bachelor’s Degree in Bio engineering.He pursued Doctor of Philosophy (PhD) studies in NUS with his research focusing on hematopoietic stem and progenitor cell (HSCP) expansion using nanomaterial-based scaffolds and small molecules. He was recipient of the prestigious President’s Graduate Fellowship from NUS that supported his graduate studies. As testimony to his research on HSPC expansion, Dr Bari has published in journals like STEM CELLS Translational Medicine (SCTM), Nanomedicine: NBM, Biology of Blood and Marrow Transplantation and Cytotherapy. He has played a critical role in crafting successful grant applications for his PI, Prof William Hwang, from national level funding agencies like National Medical Research Council (NMRC), Singapore-MIT Alliance for Research and Technology (SMART) Innovation Center, National Health Innovation Centre (NHIC) and National Research Foundation (NRF). Dr Bari was instrumental in the recent discovery of a small molecule-based platform technology that expands HSPC. This patent pending technology is currently being evaluated for commercialization and first-in-human clinical trials. Recently, Dr Bari was deeply involved in the formation of the SingHealth Duke-NUS Cell Therapy Centre and the Regenerative Medicine Institute of Singapore both of which are virtual institutes of SingHealth Duke-NUS Academic Medical Centre focusing on clinical care and translational research respectively. As part of the team for ACTRIS, Dr Bari has been instrumental in the planning and set up of ACTRIS with the area of focus/support/contribution being: program planning, manpower, innovation/regulation, funding (specifically RIE2025)/business development, stakeholder engagements, education, infrastructure and equipment.

For his notable scientific contribution Dr Bari received several awards such as Best Oral Paper (Category: Basic Sciences) – SingHealth Duke-NUS Scientific Congress 2012, First Runner Up – Best Oral Paper – Singapore Society of Hematology – Annual Scientific Meeting 2016, First Runner Up for Young Investigator’s Award (Category: Basic Sciences) – Singapore General Hospital 19th Annual Scientific Meeting 2011 as well as the Overseas Travel Fellowship Program 2014 from the Stem Cell Society (Singapore). During graduate studies, he was awarded the Best Graduate Researcher Award 2016 in the Department of Pharmacy, NUS as well as the Top Graduate Researcher Award 2016 which encompasses across the entire Faculty of Science in NUS. Recently, Dr Bari was SingHealth Quality Service Award 2021 and the SingHealth Health Manpower Development Plan Award 2020.